MOSCOW (Sputnik) – The recent shortfalls in AstraZeneca vaccine supplies to the European Union have been traced back to insufficient production of one of the drug’s components, the serum, by a European subcontractor, Politico reported on Tuesday, citing the findings of an EU investigation.